Sort by:
- Doctors (23)
- Locations (19)
ON L6H 0J8, CA
Ike Ahmed
Contact Info
Office Hours
- Today
- -
Ike Ahmed
About Ike Ahmed
Dr. Ike Ahmed obtained his Doctor of Medicine degree at the University of Toronto. He then went on to complete a residency in ophthalmology at the University of Toronto as well as a fellowship at the University of Utah’s John A. Moran Eye Center.
In addition to his duties as a surgeon and co-medical director at TLC Laser Eye Centres’ Oakville location, Dr. Ahmed also sees patients at Prism Eye Institute as well as Trillium Health Partners in Mississauga. Due to his extensive expertise in multiple areas of ophthalmology, Dr. Ahmed is regularly asked to consult for a variety of industry manufacturers and aids in the development of new platforms, devices, and technology. As a tenured professor, he also is devoted to training residents and fellows as well as teaching colleagues internationally.
Dr. Ahmed has been the recipient of numerous awards and honours. This includes the 2018 Clinical Innovator Award and the 2022 Ophthalmologist Power List Awards, which placed Dr. Ahmed as #2 of the top 100 most influential people in the field of ophthalmology. In addition, he also received the 2014 Binkhorst Medal from the American Society of Cataract and Refractive Surgeons, one of the most prestigious awards in ophthalmology given for outstanding contributions to the understanding of the practice of cataract surgery and intraocular lens implantations.
Dr. Ahmed actively contributes to ophthalmological research. He’s published over 200 peer-reviewed publications in journals such as Ophthalmology, the British Journal of Ophthalmology, the Canadian Journal of Ophthalmology, and the Journal of Cataract and Refractive Surgery. He has also given over 1,500 presentations on his research around the world.
Select Your Region
Latin America
References
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018
3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
Important Safety Information
The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.